IndraLab

Statements

KCNH2 activates Short QT Syndrome type 1. 1 / 1

| 1

reach

"Rare mutations in KCNH2, a potassium channel involved in myocardial repolarization and drug induced arrhythmias, are known to underlie congenital Long QT Syndrome type 2 and Short QT Syndrome type 1."

19305408

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

KCNH2 activates Short QT Syndrome type 1. 1 / 1

INDRA sources:

Databases

Reading